-
Trehalose Therapy for FA Gets U.S. Patent Protection
Seelos Therapeutics has received a Notice of Allowance from the U.S. Patent and Trademark Office for SLS-005 (trehalose) to treat Friedreich’s ataxia. Read more here.
What do you think of this news?
Sorry, there were no replies found.
Log in to reply.